Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Par Pharm Inc Drug Patent Portfolio

Par Pharm Inc owns 1 orange book drug protected by 1 US patent Given below is the list of Par Pharm Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7553863 Ultrapure 4-methylpyrazole 30 Jun, 2027
Active


Given below is the list of recent legal activities going on the following drug patents of Par Pharm Inc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 28 Sep, 2020 US7553863
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 23 Jun, 2017 US7553863
Post Issue Communication - Certificate of Correction 14 Sep, 2009 US7553863
Recordation of Patent Grant Mailed
Critical
30 Jun, 2009 US7553863
Patent Issue Date Used in PTA Calculation
Critical
30 Jun, 2009 US7553863
Email Notification
Critical
12 Jun, 2009 US7553863
Issue Notification Mailed
Critical
10 Jun, 2009 US7553863
Dispatch to FDC 28 May, 2009 US7553863
Application Is Considered Ready for Issue
Critical
27 May, 2009 US7553863
Issue Fee Payment Received
Critical
26 May, 2009 US7553863
Issue Fee Payment Verified
Critical
26 May, 2009 US7553863
Mail Notice of Allowance
Critical
24 Feb, 2009 US7553863
Case Docketed to Examiner in GAU
Critical
18 Feb, 2009 US7553863
Notice of Allowance Data Verification Completed
Critical
18 Feb, 2009 US7553863
Date Forwarded to Examiner 20 Nov, 2008 US7553863


Par Pharm Inc's Family Patents

Par Pharm Inc drugs have patent protection in a total of 8 countries. It's US patent count contributes only to 30.0% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Par Pharm Inc Drug List

Given below is the complete list of Par Pharm Inc's drugs and the patents protecting them.


1. Antizol

Antizol is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7553863 Ultrapure 4-methylpyrazole 30 Jun, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Antizol's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List